LEE011 Sarissa and Management Are Both Telling the Truth
A quick review of Novartis' website DOES NOT show LEE011 in Ph III trials. Hopefully they will update the site soon. However, this website [Search: Novartis LEE011 clinical trials] shows a Ph III Trial organized on 10/7/2013.
BTW ... Just because management received one bid does not mean they have to accept it. In fact, I believe it means they did not market it correctly.
Why does management want Sarissa to look like they are not being truthfull. Why didnt they disclose LEE011 going into phase 3. What part of the 2 billion in milestone payments might be paid in 2013, 2014 or 2015? How do these potential milestone payments impact the bid?